Reversible Splenial Lesion Syndrome (RESLES)
Etiology
Infection
Metabolic Disorders
Other
- Anti-Epileptic Drug Withdrawal
- Pregabalin (Lyrica) (see Pregabalin, [[Pregabalin]]) Withdrawal
- Cytokine Release Syndrome (see Cytokine Release Syndrome, [[Cytokine Release Syndrome]])
- High-Altitude Cerebral Edema (HACE) (see
Physiology
- Transient Lesions Involving the Splenium of the Corpus Callosum
Diagnosis
Brain MRI
- Round-Shaped Lesion Centered in the Splenium of the Corpus Callosum: disappears after a variable lapse
- Diffusion studies reveal DW hypersignal with low ADC values (consistent with cytotoxic edema)
- Only high altitude cerebral edema-related cases and one patient with pregabalin withdrawal showed high ADC values (consistent with vasogenic edema)
Clinical Manifestations
Neurologic Manifestations
- Non-Specific: absence of neurologic evidence of callosal disconnection
Treatment
- Correction of Underlying Disorder/Supportive Care: most cases have a complete resolution after a variable lapse
References
- Reversible splenial lesion syndrome (RESLES): what’s in a name? J Neuroimaging. 2011 Apr;21(2):e1-14. doi: 10.1111/j.1552-6569.2008.00279.x [MEDLINE]